Treatment with fluvoxamine in nonhospitalized coronavirus disease 2019 patients

Treatment with fluvoxamine in nonhospitalized coronavirus disease 2019 patients

Context Fluvoxamine may have a potential immune-regulatory action and a therapeutic role in severe acute respiratory syndrome-coronavirus (SARS-CoV-2) infection that may prevent progression and/or hospitalization. Aims Trial that compared fluvoxamine versus placebo in nonhospitalized adults with con...

Full description

Bibliographic Details
Main Authors: Mohammed A Ibrahim, Mohammed Shehta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
clinical trial
coronavirus disease 2019
fluvoxamine
nonhospitalized
nonhypoxemic
outpatients
severe acute respiratory syndrome-coronavirus
selective serotonin reuptake inhibitor
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=1;spage=40;epage=45;aulast=Ibrahim

Internet

http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=1;spage=40;epage=45;aulast=Ibrahim

Similar Items